About this event
This event was part of a series of live sessions that IMI is organising on IMI Impacts, where key actors explored the key challenges in their respective fields and demonstrate how IMI contributed. During these sessions, we also shared patients’ testimonies, as they are the ultimate beneficiaries of IMI’s funded research.
Furthermore, we engaged IMI stakeholders in a broader discussion on IMI’s impact. With this initiative, we demonstrated the successful IMI model of radical collaboration.
Agenda and presentations
Welcome and introduction
by Elisabetta Vaudano, Principal Scientific Manager, IMI
Helen Rochford-Brennan, Member and past Chair, Alzheimer Europe European Working Group of People with Dementia Recording
Q&A Time Recording
Closing remarks Recording
Professor Olivier Blin, Head of the Clinical Pharmacology & Pharmacovigilance Department, Aix-Marseille University, Member of IMI Scientific Committee
Elisabetta Vaudano, Principal Scientific Manager, IMI